Substance / Medication

Nefazodone

Overview

Active Ingredient
nefazodone
RxNorm CUI
31565

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

1 trials linked to this intervention

1
Total Trials
0
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination.
Maddux Rachel E, Riso Lawrence P, Klein Daniel N et al. · J Affect Disord · 2009
PMID: 19217168Observational
Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone.
Argyropoulos Spilios V, Hicks Jane A, Nash John R et al. · J Sleep Res · 2009
PMID: 19549078Observational
Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug.
Bauman Jonathan N, Frederick Kosea S, Sawant Aarti et al. · Drug Metab Dispos · 2008
PMID: 18332080Observational
Complete profiling and characterization of in vitro nefazodone metabolites using two different tandem mass spectrometric platforms.
Li Austin C, Shou Wilson Z, Mai Ting T et al. · Rapid Commun Mass Spectrom · 2007
PMID: 18000840Observational
Nefazodone in the treatment of generalized social phobia: a randomized, placebo-controlled trial.
Van Ameringen Michael, Mancini Catherine, Oakman Jonathan et al. · J Clin Psychiatry · 2007
PMID: 17335328Observational
Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine.
Masand Prakash S, Gupta Sanjay · Ann Clin Psychiatry · 2002
PMID: 12585567Observational
Nefazodone, psychotherapy, and their combination for chronic depression.
Rubin R T · N Engl J Med · 2000
PMID: 11023391Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Nefazodone (substance)
SNOMED CT
372491002
UMLS CUI
C0068485
RxNorm CUI
31565

Clinical Data

This intervention maps to 8 entities in the Healos knowledge graph.

2
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
1
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.